Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

In silico and Network Pharmacology Identification of Acacia senegal Phytochemicals as Potential α-Amylase Inhibitors.

INTRODUCTION Diabetes mellitus is a rapidly expanding chronic disease, prompting interest in plant-derived natural products as adjuncts to conventional therapy because of their improvements in glycaemic control and reduced complications. To evaluate phytochemicals' potential as α-amylase inhibitors using an integrated...

Abdulkadir Abdu, Hossamaldeen Bakrey, H. Rikabi et al. · 0 citations
Sep 2026

Computational identification of isoflavonoids as novel PPAR-γ agonists for the treatment of type 2 diabetes mellitus.

BackgroundThe management of type 2 diabetes mellitus (T2DM) using peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists is currently limited by the adverse effects of thiazolidinediones (TZDs), such as fluid retention and weight gain. This necessitates the search for safer natural alternatives.MethodsThis...

Abdulkadir Abdu, Hossamaldeen Bakreys, E. M. Abdulkareem et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.